News & Insights
Keyhaven Capital Partners backs Augens Capital’s investment in SRG Associati S.p.A.
Thu, 15 Jan 2026
Keyhaven Capital Partners backs Augens Capital’s investment in SRG Associati S.p.A.
Keyhaven Capital Partners backs Sullivan Street Partners’ acquisition of Zenix Aerospace
Tue, 13 Jan 2026
Keyhaven backs Sullivan Street Partners’ acquisition of Zenix Aerospace
Keyhaven Capital Partners backs Ama Capital’s acquisition of The Vella Group
Wed, 07 Jan 2026
Keyhaven Capital Partners backs Ama Capital’s acquisition of The Vella Group.
Keyhaven Capital Appoints Léa Yared de Pelleport as Head of Capital Formation
Tue, 02 Dec 2025
Keyhaven Capital is pleased to announce the appointment of Léa Yared de Pelleport as Head of Capital Formation.
Keyhaven Capital Partners announces successful exit of Amethyst Healthcare Group
Mon, 11 Aug 2025
Keyhaven announces successful exit of Amethyst Healthcare Group.
Keyhaven Capital Partners announces successful exit of OUTCO
Mon, 04 Aug 2025
Keyhaven announces successful exit of OUTCO led by Total Capital Partners.
Keyhaven Capital Partners backs Miura Partners and Evolve Healthcare Partners’ acquisition of HTBA
Mon, 06 Jan 2025
Keyhaven Capital Partners, the specialist private equity firm dedicated to the European lower mid-market, backs Miura Partners and Evolve Healthcare Partners in the acquisition of HealthTech BioActives.
Keyhaven Capital Partners backs Duke Street’s acquisition of ForLife and Trio
Tue, 03 Dec 2024
Keyhaven Capital Partners, the specialist private equity firm dedicated to the European lower mid-market, backs Duke Street’s acquisition of ForLife Group, specialists in ostomy care products operating in Germany and the UK.
Keyhaven Capital Partners announces three promotions to bolster operations
Mon, 22 Jul 2024
Keyhaven announces the promotion of three team members as the firm continues to bolster and expand its operations.
Keyhaven Capital Partners backs Miura Partners’ investment into Proclinic Group
Fri, 05 Apr 2024
Keyhaven Capital Partners co-leads the single asset GP-led investment in Proclinic Group via a more than €200 million transaction managed by Miura Partners.
Keyhaven Capital Partners announces agreement to exit Steer Automotive Group, the UK’s leading B2B automotive services platform
Wed, 17 Jan 2024
Keyhaven Capital Partners announces agreement to exit Steer Automotive Group, the UK’s leading B2B automotive services platform.
Keyhaven Capital Partners backs Alantra’s acquisition of Surexport, followed by three strategic add-on acquisitions
Mon, 23 Oct 2023
Keyhaven Capital Partners, the specialist secondaries private equity firm dedicated to the European lower mid-market, has backed Alantra in its acquisition of Surexport, Europe’s leading independent producer and distributor of fresh berries.
Keyhaven Capital Partners promotes three and makes a senior hire to bolster operations
Thu, 20 Jul 2023
Keyhaven announces the promotion of three team members and the appointment of a new Head of Fund Accounting as the firm continues to expand its operations.
Steer Automotive Group listed in The Sunday Times Hundred, recognising Britain’s fastest-growing private companies
Fri, 07 Jul 2023
We are pleased to announce that Steer Automotive Group has been recognised as one of The Sunday Times Hundred 2023, a list of Britain’s fastest-growing private companies.
Keyhaven Capital Partners announces exit from Agrupapulpi as Magnum Industrial Partners agrees sale
Wed, 14 Jun 2023
Keyhaven, the specialist secondaries private equity firm dedicated to the European lower mid-market, today announces the successful exit from its investment in Agrupapulpi, a leading Spanish producer and exporter of fruit and vegetables, following Magnum Industrial Partners’ successful sale to a US-based financial investor.
Sasha van de Water recognised as industry Changemaker
Tue, 06 Dec 2022
Keyhaven is delighted to announce that our Managing Partner Sasha van de Water has been featured amongst PEI’s 21 Changemakers, a ranking published by Private Equity International.
Keyhaven Capital Partners backs Adelis Equity Partners’ single asset continuation vehicle of SSI Diagnostica
Wed, 12 Oct 2022
Keyhaven has invested in an Adelis Equity Partners’ single asset continuation vehicle to support the growth of SSI Diagnostica.
Real Good Dental Makes Strategic Investment In Enamel Dental Group
Thu, 04 Aug 2022
TriSpan, a global private equity firm, is pleased to announce that its portfolio company, Real Good Dental (“RGD”), has made a strategic investment in the Enamel Dental Group.
Amidst strong deal activity including several recent exits, Keyhaven Capital Partners promotes six of its team, including Sarah Brereton to Partner
Wed, 13 Jul 2022
Keyhaven Capital announces the promotion of six members of its team as the firm continues to expand its operations amidst a buoyant level of investment activity—both new deals and recent attractive exits—fueled by the firm’s unique strategy and approach.
Keyhaven Capital Partners backs capital D’s acquisition of Phrasee
Wed, 16 Mar 2022
Keyhaven Capital Partners, the specialist secondaries private equity firm dedicated to the European lower mid-market, has backed capital D in its acquisition of Phrasee.